Viewing Study NCT04419402


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-04-26 @ 12:44 AM
Study NCT ID: NCT04419402
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-07
First Post: 2020-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module